-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Lexaria Bioscience Corp. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q4 2018 to Q4 2024.
- Lexaria Bioscience Corp. Share-based Payment Arrangement, Expense for the quarter ending November 30, 2024 was $99.4K, a 84.3% increase year-over-year.
- Lexaria Bioscience Corp. annual Share-based Payment Arrangement, Expense for 2023 was $170K, a 77.4% decline from 2022.
- Lexaria Bioscience Corp. annual Share-based Payment Arrangement, Expense for 2022 was $753K, a 83.6% increase from 2021.
- Lexaria Bioscience Corp. annual Share-based Payment Arrangement, Expense for 2021 was $410K, a 64% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)